| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |